Citation: Jh. Brasen et al., SURVIVAL AND CARDIOVASCULAR PATHOLOGY OF HETEROZYGOUS WATANABE HERITABLE HYPERLIPIDEMIC RABBITS TREATED WITH PRAVASTATIN AND PROBUCOL ON A LOW-CHOLESTEROL (0.03-PERCENT)-ENRICHED DIET, Virchows Archiv, 432(6), 1998, pp. 557-562
Citation: W. Kehrl et al., PROGNOSIS OF SQUAMOUS-CELL CARCINOMAS OF THE UPPER AERODIGESTIVE TRACT AND HISTO-MORPHOLOGICAL PATTERN OF LYMPH-NODE METASTASES, Laryngo-, Rhino-, Otologie, 77(10), 1998, pp. 569-575
Authors:
HARSCH M
GEBHARDT A
REYMANN A
LANG G
SCHLIACK M
LOSER R
BRAESEN JH
NIENDORF A
Citation: M. Harsch et al., EFFECTS OF PRAVASTATIN ON CHOLESTEROL-METABOLISM OF CHOLESTEROL-FED HETEROZYGOUS WHHL RABBITS, British Journal of Pharmacology, 124(2), 1998, pp. 277-282
Citation: H. Reddemann et al., PORT-SYSTEMS IN CHILDREN WITH MALIGNANCIES - OUR EXPERIENCE WITH 111 CHILDREN UNDER CANCER MANAGEMENT, European journal of cancer, 33, 1997, pp. 567-567
Authors:
HOSCH SB
KNOEFEL WT
METZ S
STOECKLEIN N
NIENDORF A
BROELSCH CE
IZBICKI JR
Citation: Sb. Hosch et al., EARLY LYMPHATIC TUMOR-CELL DISSEMINATION IN PANCREATIC-CANCER - FREQUENCY AND PROGNOSTIC-SIGNIFICANCE, Pancreas, 15(2), 1997, pp. 154-159
Citation: Jh. Brasen et A. Niendorf, ATHEROSCLEROSIS PATHOGENESIS, CLASSIFICAT ION AND FUNCTIONAL-SIGNIFICANCE, Der Pathologe, 18(3), 1997, pp. 218-227
Authors:
IZBICKI JR
HOSCH SB
PICHLMEIER U
REHDERS A
BUSCH C
NIENDORF A
PASSLICK B
BROELSCH CE
PANTEL K
Citation: Jr. Izbicki et al., PROGNOSTIC VALUE OF IMMUNOHISTOCHEMICALLY IDENTIFIABLE TUMOR-CELLS INLYMPH-NODES OF PATIENTS WITH COMPLETELY RESECTED ESOPHAGEAL CANCER, The New England journal of medicine, 337(17), 1997, pp. 1188-1194
Citation: M. Harsch et al., EFFECTS OF LOW-DOSE PRAVASTATIN SODIUM ON PLASMA-CHOLESTEROL LEVELS AND AORTIC ATHEROSCLEROSIS OF HETEROZYGOUS WHHL RABBITS FED A LOW-CHOLESTEROL (0.03-PERCENT) ENRICHED DIET FOR ONE-YEAR, Atherosclerosis, 128(2), 1997, pp. 139-147
Authors:
HOSCH SB
IZBICKI JR
PICHLMEIER U
STOECKLEIN N
NIENDORF A
KNOEFEL WT
BROELSCH CE
PANTEL K
Citation: Sb. Hosch et al., EXPRESSION AND PROGNOSTIC-SIGNIFICANCE OF IMMUNOREGULATORY MOLECULES IN ESOPHAGEAL CANCER, International journal of cancer, 74(6), 1997, pp. 582-587
Authors:
HOSCH SB
STOECKLEIN NH
REHDERS A
NIENDORF A
IZBICKI JR
Citation: Sb. Hosch et al., EXPRESSION AND PROGNOSTIC-SIGNIFICANCE OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I, ICAM-1, AND COSTIMULATORY MOLECULE B7 IN ESOPHAGEAL CANCER, Gastroenterology, 110(4), 1996, pp. 1392-1392
Authors:
NIELSEN LB
NORDESTGAARD BG
STENDER S
NIENDORF A
KJELDSEN K
Citation: Lb. Nielsen et al., TRANSFER OF LIPOPROTEIN(A) AND LDL INTO AORTIC INTIMA IN NORMAL AND IN CHOLESTEROL-FED RABBITS, Arteriosclerosis, thrombosis, and vascular biology, 15(9), 1995, pp. 1492-1502
Citation: Jh. Braesen et al., PROBUCOL INHIBITS NOT ONLY THE PROGRESSION OF ATHEROSCLEROTIC DISEASE, BUT CAUSES A DIFFERENT COMPOSITION OF ATHEROSCLEROTIC LESIONS IN WHHL-RABBITS, Virchows Archiv, 426(2), 1995, pp. 179-188
Citation: A. Gebhardt et A. Niendorf, EFFECTS OF PRAVASTATIN, A HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR, ON 2 HUMAN TUMOR-CELL LINES, Journal of cancer research and clinical oncology, 121(6), 1995, pp. 343-349
Authors:
NIENDORF A
NAGELE H
GERDING D
MEYERPANNWITT U
GEBHARDT A
Citation: A. Niendorf et al., INCREASED LDL RECEPTOR MESSENGER-RNA EXPRESSION IN COLON-CANCER IS CORRELATED WITH A RISE IN PLASMA-CHOLESTEROL LEVELS AFTER CURATIVE SURGERY, International journal of cancer, 61(4), 1995, pp. 461-464
Citation: A. Niendorf et A. Gebhardt, QUANTITATIVE-ANALYSIS OF THE MESSENGER-RN A EXPRESSION FOR THE LDL RECEPTOR AND THE HMG-COA REDUCTASE IN BOVINE-TISSUES BY COMPETITIVE RT-PCR, Der Pathologe, 15(4), 1994, pp. 201-206
Citation: A. Gebhardt et al., RAPID QUANTITATION OF MESSENGER-RNA SPECIES IN ETHIDIUM BROMIDE-STAINED GELS OF COMPETITIVE RT-PCR PRODUCTS, Journal of lipid research, 35(6), 1994, pp. 976-981